Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
R&3D is an Italian biotechnology company and Contract Research Organization (CRO) that specializes in advanced 3D cell culture models and organ-on-a-chip technologies. Founded as a spin-off from the University of Turin, the company provides innovative solutions for drug discovery, toxicology, and efficacy testing by creating physiologically relevant in vitro environments. Their platform utilizes organoids and microfluidic systems to better mimic human tissue architecture and function, aiming to bridge the gap between traditional cell culture and animal models. R&3D offers customized services to pharmaceutical, biotech, and cosmetic industries, helping to improve the predictive accuracy of preclinical studies while reducing the reliance on animal testing. The company's expertise spans various therapeutic areas, with significant focus on oncology and dermatology applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on R&3D.